Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 11 Lung Neoplasms 7 Colonic Neoplasms 5 Pancreatic Neoplasms 3 Pain, Postoperative 3 Inflammatory Bowel Diseases 3 Diverticulitis 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Male Urogenital Diseases 2 Leiomyoma 2 Inflammation 2 Carcinoma, Non-Small-Cell Lung 2 Agnosia 2 Abdominal Cancer 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Skin Neoplasms 1 Shoulder Pain 1 Respiration Disorders 1 Psychological Well-Being 1 Postoperative Complications 1 Post-thoracotomy Pain Syndrome 1 Pleural Diseases 1 Neoplasms 1 Mouth Neoplasms 1

Interventions

pembrolizumab 185 Gemcitabine 170 Paclitaxel 152 Carboplatin 137 Bevacizumab 128 Surveys and Questionnaires 118 Cisplatin 115 Docetaxel 114 Blood Specimen Collection 110 Cyclophosphamide 109 Exercise 108 Nivolumab 98 Fluorouracil 90 Capecitabine 86 Dexamethasone 81 Radiotherapy 80 Irinotecan 74 Standard of Care 69 Pemetrexed 68 Oxaliplatin 68 Leucovorin 64 Drug Therapy 64 Cetuximab 60 Erlotinib Hydrochloride 56 Sorafenib 53 atezolizumab 52 Ipilimumab 51 Doxorubicin 50 trametinib 47 Interviews as Topic 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Tea × Clear all

NCT01162642 2015-04-21

Green Tea Anticancer Mechanisms in Smokers

Ohio State University

Phase NA Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡